Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
FEBS Lett ; 582(10): 1444-50, 2008 Apr 30.
Article in English | MEDLINE | ID: mdl-18381075

ABSTRACT

To understand physiological roles of tissue mast cells, we established a culture system where bone marrow-derived immature mast cells differentiate into the connective tissue-type mast cell (CTMC)-like cells through modifying the previous co-culture system with Swiss 3T3 fibroblasts. Our system was found to reproducibly mimic the differentiation of CTMCs on the basis of several criteria, such as granule maturation and sensitivity to cationic secretagogues. The gene expression profile obtained by the microarray analyses was found to reflect many aspects of the differentiation. Our system is thus helpful to gain deeper insights into terminal differentiation of CTMCs.


Subject(s)
Cell Differentiation , Mast Cells/cytology , Mast Cells/physiology , Models, Biological , Animals , Bone Marrow Cells/cytology , Cell Culture Techniques , Cell Differentiation/genetics , Cells, Cultured , Female , Gene Expression Profiling , Histamine/analysis , Mast Cells/metabolism , Mice , Mice, Inbred BALB C , Oligonucleotide Array Sequence Analysis , Peptide Hydrolases/metabolism , Peritoneum/cytology , Swiss 3T3 Cells
2.
Biochem Biophys Res Commun ; 322(3): 1066-72, 2004 Sep 24.
Article in English | MEDLINE | ID: mdl-15336573

ABSTRACT

Prostaglandins (PGs) have been shown to play various roles in adipogenesis. In this study, we investigated on which PGE receptor subtypes are involved in the inhibition of 3T3-L1 preadipocyte differentiation. The triglyceride content of cells, used as an index of differentiation, was decreased when PGE(2), the FP-agonist fluprostenol or dibutyryl cAMP, was exogenously added to differentiation cocktails. 3T3-L1 preadipocyte cells express mRNAs for the prostanoid EP4, FP, and IP receptors. PGE(2) and the EP4 agonist AE1-329 increased cAMP levels in preadipocytes in a dose-dependent manner. AE1-329 suppressed the expression induction of differentiation marker genes such as resistin and peroxisome proliferator-activated receptor-gamma. The inhibitory effect of PGE(2) but not that of fluprostenol was reversed by the addition of the EP4 antagonist AE3-208. AE3-208 mimicked the differentiation-promoting effects of indomethacin. These results suggest that the EP4 receptor mediates the suppressive action of PGE(2) in 3T3-L1 adipocyte differentiation.


Subject(s)
Adipocytes/cytology , Cell Differentiation/physiology , Gene Expression Regulation/genetics , Receptors, Prostaglandin E/physiology , 3T3 Cells , Adipocytes/drug effects , Animals , Bucladesine/pharmacology , Cell Differentiation/drug effects , Dinoprostone/pharmacology , Gene Expression Regulation/drug effects , Mice , Prostaglandins F, Synthetic/pharmacology , RNA, Messenger/genetics , Receptors, Prostaglandin E/drug effects , Receptors, Prostaglandin E/genetics , Receptors, Prostaglandin E, EP4 Subtype , Transcription, Genetic/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...